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ABSTRACT OF THE THESIS
Cognitive Function in the Alcohol Addiction Treatment Population
by
Suranee Abeyesinhe
Doctor of Philosophy Graduate Program in Clinical Psychology
Loma Linda University, September 2014
Dr. Jason E. Owen, Chairperson

Chronic alcohol abuse has been linked to several cognitive deficits, such as
problems with spatial processing, decreased executive functioning, impaired verbal
fluency, poor working memory, response inhibition, and social problems such as
aggression and social deviance. In order for patients to benefit from treatment, they must
be able to utilize multiple cognitive functions. Research has shown that patients suffering
from cognitive impairments are much more likely to drop out of treatment early, thereby
lending them to higher relapse rates. This study aimed to identify cognitive deficits
present in the alcohol addiction treatment population, demographic factors associated
with higher levels of cognitive deficits, and whether these patients’ cognitive deficits
predict treatment dropout. Results of this study indicated that patients in the addiction
treatment program at the LLUBMC evidenced reductions in visuospatial abilities,
immediate memory, delayed memory, and overall cognitive function. Further, in this
population, below average delayed memory significantly predicted treatment dropout.
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CHAPTER ONE
INTRODUCTION

Over 17 million people in the United States are alcoholics or suffer from alcohol
abuse problems (NIH). Alcoholism can lead to a variety of different problems, including
social, psychological, cognitive, and medical ailments. In 2009 alone, alcohol abuse
treatment made up 42% of the near 2 million substance abuse admissions into treatment
programs. Further, relapse rates in this population remain relatively high; research
findings vary depending on the definition of relapse. With the various implications
alcohol addiction and abuse create on society, it is important for us to study the cycle of
addiction, as well as the cognitive deficits that may impact treatment completion and
efficacy.
There are many neurobiological and social factors that interact in the cycle of
addiction. Neurobiologically speaking, there are several neurotransmitters that positively
reinforce the effects of alcohol use. Social factors magnify these effects, making it very
difficult for an individual to break the cycle of addiction. Effective addiction treatment
may be the only solution for many people suffering from alcoholism or alcohol abuse.
Currently, there are a number of treatment modalities that have been shown to be
effective. The Minnesota Model, Cognitive Behavioral Therapy, Motivational
Enhancement Therapy, and Twelve-step Facilitation are some of the most commonly
used addiction treatments. Although these treatments have been shown to have positive
results, there is no modality of treatment that directly targets the cognitive deficits
experienced by those individuals suffering from alcohol addiction.
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Chronic alcohol abuse has been linked to several cognitive deficits, such as
problems with spatial processing, decreased executive functioning, impaired verbal
fluency, poor working memory, response inhibition, and social problems such as
aggression and social deviance. In order for patients to benefit from treatment, they must
be able to utilize multiple cognitive functions. It has been shown that patients suffering
from cognitive impairments are much more likely to drop out of treatment early, thereby
lending them to higher relapse rates.
This study aims to identify the most commonly presented cognitive deficits in the
alcohol addiction treatment population. We also aim to explore demographic factors that
may be associated with higher levels of cognitive deficits. Finally, we will examine
whether patients’ cognitive deficits have an effect on completion of the treatment
program at the Loma Linda Behavioral Medical Center. By identifying specific cognitive
deficits present in this population, a more tailored treatment plan may be implemented in
the future in order to increase treatment completion and reduce relapse rates.
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CHAPTER TWO
BACKGROUND
The National Institute on Drug Abuse has defined addiction as a “chronic
relapsing disease characterized by compulsive drug-seeking and abuse and by longlasting chemical changes in the brain.” Generally, there are genetic, psychosocial, and
environmental factors that contribute to the development of this disease.
The following tables from the DSM-IV describe the criteria for substance abuse and
substance dependence:

Table 1
DSM Criteria of Substance Abuse
A maladaptive pattern of substance use leading to clinically significant
impairment or distress as manifested by one (or more) of the following, occurring
within a 12-month period:
1. Recurrent substance use resulting in a failure to fulfill major role obligations at
work, school, or home
2. Recurrent substance use in situations in which it is physically hazardous
3. Recurrent substance-related legal problems
4. Continued substance use despite having persistent or recurrent social or
interpersonal problems caused or exacerbated by the effects of the substance
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Table 2
DSM Criteria of Substance Dependence
Substance dependence is defined as a maladaptive pattern of substance use leading
to clinically significant impairment or distress, as manifested by three (or more) of
the following, occurring any time in the same 12-month period:
1. Tolerance, as defined by either of the following: (a) A need for markedly
increased amounts of the substance to achieve intoxication or the desired effect
or (b) Markedly diminished effect with continued use of the same amount of
substance.
2. Withdrawal, as manifested by either of the following: (a) The characteristic
withdrawal syndrome for the substance or (b) the same (or closely related)
substance is taken to relieve or avoid withdrawal symptoms.
3. The substance is often taken in larger amounts or over a longer period then
intended.
4. There is a persistent desire or unsuccessful efforts to cut down or control
substance use.
5. A great deal of time is spent in activities necessary to obtain the substance, use
the substance, or recover from its effects.
6. Important social, occupational, or recreational activities are given up or
reduced because of substance use.
7. The substance use is continued despite knowledge of having a persistent
physical or psychological problem that is likely to have been caused or
exacerbated by the substance
(DSM–IV–TR (2000) 4th ed., text rev.).

Alcohol addiction can cause a number of medical, social, and psychological
problems. According to the Center for Disease Control, immediate risks associated with
excessive alcohol use include unintentional injuries such as car accidents, falls, drowning,
and firearm injuries; alcohol poisoning; violence, such as domestic disputes and child
maltreatment; risky sexual behaviors; miscarriages and birth related defects. Long term
risks associated with excessive alcohol use can lead to the development of chronic
diseases, neurological problems, and social problems.
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Scope of the Problem
The economic cost of drug abuse in 2002 was estimated at $180.9 billion. This
value represents both the use of resources to address health and crime consequences as
well as the loss of potential productivity from disability, death and withdrawal from the
workforce. Further, alcohol related arrests have significantly contributed to the doubling
of the nation's incarceration rate since 1985. Risk for relapse is high and maybe even
higher among sensitive subpopulations such as those presenting to treatment with
complex comorbidities (Office of National Drug Control Policy).
According to the United States Substance Abuse and Mental Health Services
Administration (SAMHSA) in 2009, almost 2,000,000 substance abuse treatment
admissions for people aged 12 and older were reported in the United States. Five major
substance groups accounted for 96 percent of these 2 million admissions: alcohol (42%),
opiates (21%), marijuana (18%), cocaine (9%), and methamphetamines/amphetamines
(6%). The average age at admission was 34 years, with non-Hispanic Whites making up
60 percent of all treatment admissions (followed by Blacks at 21%, Hispanics at 14%,
and other racial groups at 5%). There was no significant difference in gender at
admission; females made up 51 percent of admissions, males made up 49 percent.
Relapse rates for addictive diseases are usually in the range of 50% to 90%;
however, these rates vary by definition of relapse, severity of addiction, which drug of
addiction, length of treatment, and elapsed time from treatment discharge to assessment,
as well as other factors (National Institute on Drug Abuse). A study by Dawson et al.
(2007) found that 25% of alcohol dependent subjects had relapsed in a 3-year follow up
from an abstinence based treatment program, as evidenced by a recurrence of any alcohol
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use disorder symptoms. Another study found that one-third of people who enter
treatment trials are in full remission from alcohol dependence during the following year
(Miller et al. 2001). These figures apply to those who actually enter and participate in
treatment, and ignore the majority of alcohol dependent people who do not utilize a
treatment program to gain sobriety. A study by Dawson et al. (2006) stated that about
three-quarters of people with alcohol dependence reduce or stop drinking without any
kind of professional treatment or interaction in support groups such as AA. This is an
important consideration to make, as relapse rates among this population are not likely
evaluated.

Neurobiology of Addiction
Addiction has been conceptualized as a chronic, relapsing disorder with roots in
both impulsivity and compulsivity, with neurobiological mechanisms that influence how
an individual moves through the addiction cycle. The typical behavioral cycle progresses
as such: binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation.
Impulsivity and compulsivity can coexist at different stages of this cycle (Koob, 2009).
Further, five specific systems of neurotransmitters have been identified as playing a part
in the positive reinforcing effects of alcohol use: dopamine, opioid peptides, aminobutyric acid, glutamate, and endocannabinoids.
The cycle of addiction involves an activation of brain pleasure centers, which
involve these different neurotransmitters. First, upon ingesting the drug of choice, there is
an increase in extracellular dopamine levels in the nucleus accumbens. Once experienced,
drug euphoria promotes the repeated use of the addictive drug, especially if genetic traits

6

enhance the pleasurable effect. Evidence shows that in those with a genetic predisposition
toward alcoholism, there may be an exaggerated -endorphin response, leading to a
greater experience of pleasure. Over time, addictive drugs disrupt reward circuits and
produce states of withdrawal and craving, which provide negative feedback, leading to
drug-seeking behavior. Craving is a phenomena that can be amplified by stimuli that have
become associated with drugs through conditioning. Neuroimaging has shown a link
between cue-induced craving and brain function, which is arguably the most persistent
and insidious clinical component of addiction (Dackis & O’Brien, 2005).
Other neuroimaging studies of brains of individuals with alcohol use disorders
show increases in ventricular and sulcal cerebrospinal ﬂuid volumes, suggesting a
corresponding loss of cerebral tissue. Further studies have found associations between
ventricular enlargement and poor performance on neuropsychological measures (Jernigan
& Ostergaard, 1995). Magnetic resonance imagery (MRI) studies have also been
conducted among alcoholics, and have shown loss of volume of the grey and white
matter, especially in the prefrontal region (Sullivan, 2005). PET imaging has similarly
been used to visualize the damage that heavy alcohol consumption has on the living
brain. A study by Wong et al. (2003) found deficits in alcoholics, particularly in the
frontal lobes, which are responsible for numerous functions associated with learning and
memory, as well as in the cerebellum, which controls movement and coordination.

Impact of Alcohol on Cognitive Functions
It is important to distinguish between deficits that occur during alcohol
intoxication, and those that persist after the effects of alcohol have worn off, especially in
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those who abuse the substance. During intoxication, common symptoms experienced
include impaired memory, slowed reaction times, slurred speech, blurred vision, poor
judgment, and difficulty walking. For most individuals, these impairments subside after
drinking has stopped. However, those who drink heavily over long periods of time may
experience deficits that persist well after sobriety is achieved.
There are many factors that contribute to the extent to which alcohol affects the
brain. Some of these factors include how much and how often alcohol is consumed, how
old the person was when he or she started drinking, whether he or she was exposed
prenatally to alcohol, familial history of alcoholism, demographic variables, and general
health status. It has been found that older age, lower education, health problems,
psychiatric diagnoses, familial alcoholism, and duration of heavy drinking, have been
inversely related to neuropsychological ability (Bates et al., 2006).
Chronic alcohol abuse has been linked to several cognitive deficits that affect
aspects of everyday life. Some of these include deficits in spatial processing (Fein et al.,
2006), decreased executive functioning (Glass et al., 2009), and impaired verbal fluency
and decision making (Fernandez-Serrano et al., 2010). Other behavioral disturbances that
occur with alcohol use include increased impulsivity and aggression (Bjork et al., 2004)
and proneness to social deviance and disadvantageous decision making (Fein et al.,
2004).
Cummings (1995) examined the relationship between structural and functional
damage to the prefrontal and temporal brain areas and related circuits in heavy drinkers
and the neuropsychological deficits associated with these areas to be significant, as they
are responsible for memory, strategic planning, use of environmental feedback, working
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memory, goal-setting, and response inhibition. These functions play a major role in
treatment outcome, as these abilities are necessary for patients to be successful in alcohol
addiction recovery.
Further, when examining neurocognitive deficits in sober alcoholics compared to
peer nonalcoholic controls, Parsons (1998) found that both male and female alcoholics
had deficits on tests of learning, memory, abstracting, problem-solving, perceptual
analysis and synthesis, speed of information processing, and efficiency.
In order to examine the genetic influence on alcohol related cognitive deficits,
Gurling et al. conducted a monozygotic twin study in 1991. This study found that a twin
with high alcohol consumption performed significantly worse overall on cognitive tests
than their co-twin. Specifically impaired were visual spatial ability and recognition,
vocabulary, category sorting, and tactual performance. Further, the number of years of
problem drinking was correlated with lower scores on subtests of tactual performance.

Recovery of Function
Some of the most severe impairments associated with heavy alcohol consumption
may resolve soon after drinking stops, however some functions may take months or even
years to recover. Manning et al. (2008) conducted a study on neuropsychological changes
that occur in patients after alcohol detoxification. They found that there were significant
increases in post-detoxification scores on measures of working memory, verbal fluency,
and verbal inhibition, but not in non-verbal executive function tasks, such as mental
flexibility and planning ability.
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Current Addiction Treatment
The most used addiction treatment modalities are the following:
The Minnesota Model takes a holistic approach, involving a multidisciplinary
team of professionals (physicians, nurses, psychologists, social workers, and clergy) and
recovering staff members (counselors). It combines the foundational knowledge of
recovery with the Alcoholics Anonymous (AA) 12 steps and principles. Treatment
consists of individual interviews, small group therapy, psychoeducation, and AA stories
of recovery. In this model, connections with AA groups and community members were
seen as crucial for maintaining sobriety post-treatment (Anderson, 1999).
Cognitive Behavioral Therapy (CBT) seeks to help patients recognize, avoid, and
cope with the situations in which they are most likely to abuse substances. It focuses on
teaching skills such as drink refusal and relapse prevention.
Motivational Enhancement Therapy (MET) focuses on addressing ambivalence
about and motivation to change.
Twelve Step Facilitation (TSF) focuses on teaching that alcoholism is a disease
that requires abstinence and affiliation with Alcoholics Anonymous (AA).
Project MATCH, a clinical trial by the NIAAA that examines patient-treatment
interactions, found that for the most part, CBT, MET, and TSF all had highly similar and
positive results (Project MATCH Research Group 1998). However, a study conducted by
Bates et al. (2005) found that individuals who were assigned to TSF showed more
improvement in latent executive ability compared to those assigned to CBT and MET.
The rationale given was that the techniques of TSF may have contributed to cognitive
recovery by increasing the likelihood of sustained abstinence by breaking down complex,
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long-term goals into small manageable subgoals, allowing clients to accumulate a history
of success.
Alcohol addiction treatment is a complicated process, incorporating many
different psychological, social, and medical aspects. In order for treatment to be effective,
there are key elements that must be met. In a study conducted by Kellogg and Tatarsky
(2010), 25 clinicians in New York convened at a roundtable to discuss what psychosocial
factors play a part in successful treatment for addictions. There was agreement that
treatment plans should be individually specific and emphasize improving patients’ sense
of self-efficacy. Further, the relapse prevention model was almost universally endorsed.
The group of clinicians also endorsed the idea that long-term recovery is dependent on
embracing new personal and social identities that replace those that were based on their
substance use.

Cognitive Deficits and Treatment Efficacy and Outcomes
Why is it important to examine cognitive deficits in the addiction population?
Research on drug abuse, including alcohol use, has yielded findings suggesting that in
order for patients to initiate and maintain behavioral change, they must be able to utilize
multiple cognitive functions (Weinstein & Shaffer, 1993); users with cognitive
impairments are much more likely to drop out of treatment early, and show less
engagement in the treatment process (Aharonovich et al., 2006; Teichner et al., 2002).
Another study found that greater cognitive impairment predicted less treatment
compliance, and lower self-efficacy, in turn, predicting drinking outcomes, with less
treatment and lower self-efficacy leading to fewer days of abstinence and more drinks per
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drinking day (Bates et al., 2006).
A study by Blume et al. (2005) investigated stage of change and cognitive factors
in an alcohol dependent population. They found that lower verbal and higher delayed
recall memory scores predicted a precontemplative stage of change, whereas higher
verbal memory scores predicted a contemplative stage of change. Further, better attention
and concentration predicted reduced drinking at a 3-month follow up.
Currently, there are few studies documenting specific cognitive deficits
experienced by those abusing alcohol. However, there are even fewer studies that address
how these deficits influence treatment outcomes. This study aims to investigate this
relationship, hypothesizing that those patients with more severe cognitive deficits will
have poorer treatment outcomes. Clinically, this may be useful in devising new treatment
protocols that can target and enhance individual’s cognitive deficits, directly improving
treatment outcomes.

Confounding Factors
A few variables have been identified as confounding factors to cognitive
functions. Some of these include previous traumatic brain injury, familial alcoholism,
childhood behavioral problems, psychopathology, and ongoing medical issues (Bates,
2002). A study conducted by Miller (1995) found that the prevalence of alcohol and drug
use disorders is more than 50% among head trauma victims. Head trauma alone lends
itself to a host of cognitive deficits, and paired with alcohol use, these deficits may be
even more detrimental to an individual. It is important to assess for previous head trauma,
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in the likelihood that it either serves as a risk factor for alcohol abuse and/or is
responsible for some variance of measured cognitive functions.

Clinical Implications
Cognitive rehabilitation may enhance current addiction treatment modalities. It
can address deficits in attention, memory, learning, and problem solving, enabling a
patient to engage and utilize treatment strategies more effectively. Fals-Stewart and Lam
(2010) found that patients who underwent computer-assisted cognitive rehabilitation in
addition to standard treatment were more engaged and committed to treatment, and
reported better long-term outcomes (higher percentage of days abstinent after treatment).

Aims and Hypotheses
The first aim of this study will be to identify the cognitive deficits present in
alcohol addiction treatment patients. The hypothesis is that participants will have below
average scores on all five domains and overall score on the RBANS.
The second aim of this study is to evaluate the effect of demographic variables on
cognitive function. The hypothesis is that lower income, fewer years of education,
heavier drinkers, and those who began drinking at a younger age will have poorer
cognitive function.
The third aim of this study will be to evaluate the relationship between cognitive
deficits and treatment completion. The hypothesis is that those with poorer cognitive
performances will have poorer treatment completion rates.
The fourth, and final, aim of this study will be to evaluate how other risk factors
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such as comorbid mental health diagnosis and prior termination of rehabilitation
programs affect treatment completion. The hypothesis is that those with comorbid mental
health diagnoses and/or prior treatment termination will have poorer rates of treatment
completion.
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CHAPTER THREE
MATERIALS AND METHODS

Participants
Participants will be recruited from consecutive admissions to an intensive
outpatient chemical dependency treatment program at the Loma Linda Behavioral
Medical Center (LLUBMC). All participants will be detoxified at the LLUBMC, and will
be medically stable at outpatient treatment entry. Participants aged 20-89 will be included
in the study.

Procedure
Participants of the chemical dependency treatment program will be recruited for
the study during their first week at the LLUBMC. Once the patient has completed the
inpatient detoxification program, he/she enters the outpatient partial hospitalization
program, and will be approached to participate in this study. Informed consent will be
obtained by a trained clinical researcher (explaining the study aims, design, and
risks/benefits), and signed documents will remain in a secured office. A verbal survey
will also be given to the participants at the time of consent. This survey will include
questions regarding history of alcohol use, severity, and at what age the subject began
drinking. Issues regarding familial alcoholism, childhood behavioral issues,
psychopathology, previous head trauma, and medical issues will also be assessed. See
Appendix A. During their first two days of the outpatient program, consenting patients
will be given a brief neuropsychological battery, the Repeatable Battery for the
Assessment of Neuropsychological Status (RBANS).
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Instruments
A survey collecting demographic information, alcohol use history, and
confounding factors will be verbally administered (see Appendix A).
The RBANS is a brief, individually administered test that helps to determine the
neuropsychological status of adults who have neurologic injury or disease. The test
consists of five indexes: immediate memory, visuospatial/constructional, language,
attention, and delayed memory. There are 12 subtests of the RBANS, including: list
learning, story memory, figure copy, line orientation, digit span, symbol digit coding,
picture naming, semantic fluency, list recall, list recognition, story recall, and figure
recall. The total scale score provides a global measure of neuropsychological functioning.
The RBANS utilized a United States population-based normative standardization, and
data are scaled using age-based norms and percentiles.
The overall battery takes about 30 minutes to administer, creating a time frame
that maximizes patient cooperation and minimizes effects of fatigue on performance. The
RBANS was also designed to bridge the gap in cognitive assessment, being sensitive to
mild impairment as well as severe dementia, enabling its use for normal older adults as
well (Randolph, 1998). The RBANS has two parallel forms, which is ideal for measuring
change in the patient’s neuropsychological status over time. This measure was originally
used as a tool to assess dementia in elderly patients, however it has demonstrated clinical
utility amongst a wide range of neuropsychological and psychiatric populations, such as
with traumatic brain injury (McKay et al., 2007), schizophrenia and bipolar disorder
(Dickerson et al., 2004), and anorexia nervosa (Mikos et al., 2008). It was also used in a
study that assessed cognitive ability in college athletes that participated in contact sports

16

(Killam et al., 2005). In the addiction population, the RBANS has been used with
veterans residing in a substance abuse treatment program, and indicated post-treatment
increases in immediate memory and attention (Schrimsher and Parker, 2008). Curry and
Stasio (2009) also used the RBANS in a study evaluating the effects of alcohol and
energy drinks on neuropsychological performance, finding deficits in
visuospatial/constructional and language performance scores.
Scoring for the RBANS is as follows: each subtest yields a subtest raw score.
These scores are then transferred to a score summary sheet that combines subtests into
the specified domains, yielding an index score. Each index score will also be converted to
percentile scores, utilizing the age-based normative conversions provided in the RBANS
manual.

Variables to be Examined
Demographic Data
Age, gender, years of education, and income will be collected from the
multidisciplinary patient assessment conducted at intake to the chemical dependency
program. Education will be coded as a continuous variable. Income will be coded as a
categorical variable with the following values: <10k, 10-35k, 35-60k, 60-80k, and 80k+.

Substance Abuse History
Information regarding substance abuse history will be collected from the verbal
survey given to the participants at the time of consent. The variables of interest are age at
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first drink, and general number of drinks consumed in one sitting during heaviest period
of drinking. Both variables will be coded as continuous variables.

Cognitive Function
Five domains of neuropsychological functioning will be assessed by the RBANS.
Each domain consists of two subtests, with the exception of the delayed memory domain,
which has four subtests. Each of the following domains will be evaluated:

Immediate Memory
This domain measures one’s ability to remember a small amount of information
immediately after it is presented. In order to test this domain, the following subtests of
the RBANS are used.
List Learning
This consists of a list of 10 unrelated words, read for immediate recall over four
trials, for a total maximum score of 40. The words are of moderate-high imagery and low
age-of-acquisition, thereby reducing possible education effects on performance and
easing translation.
Story Memory
This consists of a 12-item story, read for immediate recall over two trials, for a
total maximum score of 24. Scoring is based upon verbatim recall, and the stories
contained in the different forms of the RBANS follow the same basic structure.
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Visuospatial Ability
This domain allows one to analyze, understand, and recreate spatial relations. For
example, this includes ability to mentally rotate objects, estimate distance and depth, and
navigate the surrounding environment. The following RBANS subtests are used to
evaluate this domain.
Figure Copy
This consists of the direct copy of a complex geometrical figure, similar to the
Rey-Osterrieth figure, but somewhat less demanding. There are 10 components of the
figure, and a structured simplified scoring guide (contained on the record form) yields a
maximum score of 20. There is an additional detailed scoring guideline and associated
transparency available as of 2008 to improve inter-rater reliability in scoring this subtest
(this is the only subtest for which scoring is not entirely objective).
Line Orientation
Subjects are shown an array of 13 lines, fanning out from a common point of
origin through 180 degrees. For each item, two target lines are shown beneath the array,
and subjects must identify which lines they match within the array. There are 10 items,
each containing two lines to be matched, for a total maximum score of 20.

Language
This domain includes one’s ability to acquire and utilize a system of
communication, and the ability to respond verbally to naming or retrieving learned
material. The following subtests examine this domain.
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Picture Naming
This is a confrontation naming task, with 10 line drawings of objects that must be
named by the subject.
Semantic Fluency
Subjects are given 60” to provide as many exemplars as they can from a given
semantic category (e.g., fruits and vegetables).

Attention
This domain evaluates one’s ability to select a subset of information to focus on
for enhanced processing and integration. It examines the examinee’s capacity to
remember and manipulate both visually and orally presented information in short-term
memory storage. The following two subtests make up this domain.
Digit Span
This is a classic digit repetition test of working memory, with stimulus items
increasing in length from 2 digits to 9 digits. Items are administering in order of length,
and the test is discontinued after failure of two items at a given string length.
Coding
This processing speed subtest is very similar to the Digit Symbol subtest of the
Wechsler scales. Subjects must fill in digits corresponding to shapes as quickly as they
can on the basis of a coding key. After completing practice items, subjects have 90” to
complete as many items as they can.
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Delayed Memory
This domain explores one’s ability to remember information after a period of
time. In order to test this domain, these subtests are given to participants 20 minutes after
original presentation.
List Learning Free Recall
Free recall of the words from the initial List Learning subtest (max=10).
List Learning Recognition
Yes/No recognition for the words from List Learning, with 10 foils (max=20).
Story Memory Free Recall
Free recall of the story from the Story Memory subtest (max=12).
Figure Free Recall
Free recall of the Figure from the Figure Copy subtest (max=20).

Total Score
This score is a combination of all domain scores that represents a global measure
of neuropsychological functioning.

Completion of Treatment
A binary variable will be created in order to evaluate whether subjects completed
the intensive outpatient treatment.

Planned Analyses
The first aim of this study will be to identify the cognitive deficits present in
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alcohol addiction treatment patients. The hypothesis is that participants will have below
average scores on all five domains and overall score on the RBANS. The analyses that
will be conducted to evaluate this hypothesis will include: computing subtest and index
scores using RBANS normative data, descriptive data analysis in order to see most
common deficits, Welch’s t-tests to investigate significant differences between sample
and normative performances on each subtest, and one-sample t-tests to evaluate whether
the group index scores are significantly different from an average index score of 100.
The second aim of this study is to evaluate the effect of demographic variables on
cognitive function. The hypothesis is that lower income, fewer years of education,
heavier drinkers, and those who began drinking at a younger age will have poorer
cognitive function. The analyses to be performed for this hypothesis will include six
stepwise linear regressions (one for each domain and overall score on the RBANS), with
the independent variables including income, education, severity of drinking, and age at
first drink, and the dependent variable being each cognitive domain index score.
The third aim of this study will be to evaluate the relationship between cognitive
deficits and treatment completion. The hypothesis is that those with poorer cognitive
performances will have poorer treatment completion rates. Logistic regressions will be
utilized to test this hypothesis. In each of the six regressions, the independent variable
will be each cognitive domain index score, and the dependent variable will be the
dichotomous treatment completion variable.
The fourth, and final, aim of this study will be to evaluate how other risk factors
such as comorbid mental health diagnosis and prior termination of rehabilitation
programs affect treatment completion. The hypothesis is that those with comorbid mental
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health diagnoses and/or prior treatment termination will have poorer rates of treatment
completion. Two separate logistic regressions will be performed. To investigate the effect
of mental health on treatment completions, the regression will include mental health
comorbidity as the independent variable, and completion of treatment as the dependent
variable. In order to investigate the effect of prior termination of treatment, a sub-dataset
will be created for only those who attended a previous addiction treatment program.
Using this sub-dataset, a logistic regression will be utilized, with prior dropout being the
independent variable, and treatment completion as the dependent variable.
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CHAPTER FOUR
RESULTS

Statistical Analyses
The primary outcome measure was completion of treatment. Risk factors of
primary interest were individual’s index scores for the following cognitive domains:
attention, language, visuospatial, immediate memory, delayed memory, and overall
cognitive functioning. Also of interest were demographic factors (age, gender, race,
marital status, education, income), severity of consumption (drinks per sitting, age at first
drink), comorbid mental health diagnoses, and prior treatment dropout. For the analyses
conducted, a p value of 0.05 was considered significant, and a 95% confidence interval
(CI) was used. The computer statistical software package SPSS (version 22) was used for
all analyses. GraphPad software was also utilized for Welch’s unpaired t-test analyses.
The cognitive domain variables were also transformed from index score variables
into dichotomous ability classification variables (below average vs. average and above)
for ancillary analyses in order to further examine their effects.

Patient Population
Patients admitted to the outpatient Chemical Dependency Partial Hospitalization
Program (PHP) at the LLUBMC from May of 2013 through March 2014, with a primary
alcohol abuse diagnosis were considered in the final analysis. 2 patients were excluded
due to missing information. The total number of patients included in this data analysis
amounted to 25.
The clinical characteristics of patients enrolled in the Chemical Dependency PHP
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are shown in Table 3. Information on age, gender, race, marital status, education, and
income were assessed upon admission. The average age at admission was 46.3. Males
made up the majority of the treatment population, constituting 56% of the patient pool.
The ethnic majority of this population was Caucasian (56%), and 60% of patients were
married. Patient’s educational background varied, with 40% of patients having a high
school diploma or GED, 28% completing some college, 24% completing a Bachelor’s
degree, and 2 patients (8%) held graduate level degrees. About half of the patients
reported an annual income of over $80,000, followed by 40% of patients making between
$35,000-$80,000, and only 3 (12%) of patients making less than $35,000 a year. In
regard to treatment completion, 16 out of 25 patients (64%) completed treatment.
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Table 3
Descriptive Statistics for the LLUBMC patient population
Total N = 25
Gender
Male
Female
Race
Caucasian
Hispanic
African American
Asian
Other
Marital Status
Married
Separated
Divorced
Single
Education
High School
Some College
Bachelor’s
Master’s/Doctorate
Income
<10k
10-35k
35-60k
60-80k
80k+

Age

N (%)
14 (56)
11 (44)
14 (56)
7 (28)
1 (4)
1 (4)
2 (8)
15 (60)
3 (12)
2 (8)
5 (20)
10 (40)
7 (28)
6 (24)
2 (8)
1 (4)
2 (8)
5 (20)
5 (20)
12 (48)
Mean
46.3

Cognitive Deficits Among Patients
The first hypothesis of this study was that the patients undergoing alcohol
addiction treatment will have poorer cognitive functioning than the general population.
In order to evaluate the profile of cognitive deficits present within this sample, a
frequency analysis was conducted in order to identify frequencies of individual’s index
scores on each cognitive domain. In conjunction with standard neuropsychological
cutoffs that identify scores equivalent to 1 standard deviation below the mean to signify
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reduced functioning, the number of patients in this population that scored in the below
average range, and the sample means by domain, are depicted in Table 4 below.

Table 4
Cognitive Deficits Among Participant Sample
Cognitive
Domain
Mean of Index
Score

Below
Average

Attention

Language

Visuospatial

Immediate
Memory

Delayed
Memory

Total

97.72

98.32

91.84

92.2

93.84

92.76

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

6 (24)

3 (12)

7 (28)

10 (40)

6 (24)

8 (32)

In regard to attention, 24% of the participants scored below average. On the test
of language abilities, 12% performed below average. In regard to visuospatial
functioning, 28% of the participants scored below average. On tests of memory, 40% of
participants scored below average on immediate memory, and 24% of participants scored
below average on delayed memory. Finally, participants’ overall cognitive function was
also evaluated and 32% of participants scored in the below average range.

Normality of Distributions
To further investigate the normality of the distributions present in this sample,
Shapiro-Wilk tests of normality, skew, and kurtosis analyses were run. According to
these analyses, this sample’s performance did not significantly differ from a normal
distribution. See Tables 5 and 6 below.
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Table 5
Shapiro-Wilk Tests of Normality
Cognitive Domain

Statistic

df

p

Attention

.929

25

.084

Language

.952

25

.271

Visuospatial

.974

25

.755

Immediate Memory

.971

25

.660

Delayed Memory

.967

25

.565

Overall Cognitive Function

.957

25

.360

Figures 1 through 6 below illustrate the distributions present in this sample on
each domain of the RBANS, including a normal distribution curve for reference.

Figure 1. Bar graph showing this sample’s performance on
the Attention domain compared to a normal distribution
curve.
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Figure 2. Bar graph showing this sample’s performance on
the Language domain compared to a normal distribution
curve.

Figure 3. Bar graph showing this sample’s performance on
the Visuospatial domain compared to a normal distribution
curve.
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Figure 4. Bar graph showing this sample’s performance on the
Immediate Memory domain compared to a normal distribution
curve.

Figure 5. Bar graph showing this sample’s performance on the
Delayed Memory domain compared to a normal distribution curve.
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Figure 6. Bar graph showing this sample’s performance on
the Overall Cognitive domain compared to a normal
distribution curve.

Comparison to General Population
In order to evaluate the hypothesis that this sample will perform below the
normative sample, the means of this sample’s performances on each subtest were
compared to those of the general population, using subtest means established in the
RBANS manual, which were derived from a standardized sample of 540 people.
According to Welch t-test results, the mean scores on the list learning subtest were
significantly lower in this sample population (M = 25.6, SD = 3.85) than in the general
population (M = 28.45, SD = 4.48), t(41) = 3.165, p = .003. Mean scores on the figure
copy subtest were also significantly lower in this sample population (M = 17.04, SD =
2.11) than in the general population (M = 18.43, SD = 1.45), t(29) = 3.115, p = .004. See
Table 6 below for all subtest means.
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Table 6
Comparison of Sample Group Subtests to Normative Group means
Sample Group
Subtests
Mean
SD
List Learning*
25.6
3.85
Story Memory
17.16
3.54
Figure Copy*
17.04
2.11
Line Orientation
16.76
3.27
Picture Naming
9.68
0.63
Semantic Fluency
21.64
5.45
Digit Span
10.88
2.30
Coding
47.88
10.22
List Recall
5.60
2.08
List Recognition
19.44
0.87
Story Recall
8.68
2.48
Figure Recall
12.80
3.58
*comparison is significant at the .01 level

Normative Group
Mean
SD
28.45
4.48
17.98
3.43
18.43
1.45
16.3
2.95
9.53
0.8
21.1
4.58
10.75
2.3
49.68
8.43
6.45
2.0
19.58
0.88
9.35
2.05
14.18
3.38

In order to identify if these performances are significantly different from a mean
index score of 100, one sample t-tests were performed, comparing the means of each
domain of cognitive function against a test value of 100. The results of this analysis show
that in this sample population, their mean performances on domains of visuospatial,
immediate memory, and overall cognitive function were significantly lower than mean
index scores. See Table 7 below.

Table 7
One-sample t-tests of Cognitive Domain Means Against a Test Value of 100
t

df

p

Mean
Difference

Visuospatial*

-.731
-.603

24
24

.472
.552

-2.28000
-1.68000

-8.7152
-7.4315

4.1552
4.0715

Language

-2.678

24

.013

-8.16000

-14.448

-1.8720

Immediate Memory*

-2.713

24

.012

-7.80000

-13.733

-1.8671

Delayed Memory

-1.951

24

.063

-6.16000

-12.677

.3565

Overall Cognitive Function*
* significant at the 0.05 level

-2.827

24

.009

-7.24000

-12.525

-1.9548

Cognitive Domain
Attention
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95% C.I.

Cognitive Profile of this Population
In order to create a cognitive profile of this sample, the mean index scores of each
domain were evaluated. The graph below (Figure 7) depicts the overall performance of
this sample. T-tests were utilized in order to identify if there was a significant difference
between domains. There was no statistical difference domain by domain, but in
conjunction with the above t-tests, the profile suggests higher scores on attention and
language, and lower scores on visuospatial abilities, immediate memory, and overall
cognitive function.

160

Index Scores

140
120
100
80
60
40
Attention

Language

Visuospatial

Immediate Delayed
Memory
Memory

Overall
Score

Figure 7. Sample Performance on RBANS using Index Score Means

Predictors of Cognitive Function
The second hypothesis of this study was that lower income, fewer years of
education, younger age at first drink, and more drinks per day would negatively affect
each domain of cognitive function. Six stepwise linear regressions were run in order to
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determine if these four variables predicted performance on each domain index of
cognitive function: attention, language, visuospatial, immediate memory, delayed
memory, and overall cognition. In four of the six analyses, years of education was the
only significant predictor of cognitive functions, and entered into the regression
equations. See Tables 8-11 below. Contrary to the hypothesis, income, age at first drink,
and number of drinks per day were not significant predictors of cognitive functioning (p
> .05). However, years of education was significantly related to: visuospatial ability, F (1,
23) = 9.754, p = .005, indicating that approximately 30% of the variance of the
visuospatial score could be accounted for by years of education; immediate memory, F
(1, 23) = 4.536, p = .044, indicating that approximately 17% of the variance of the
immediate memory score could be accounted for by years of education; delayed memory,
F (1, 23) = 6.068, p = .022, indicating that approximately 21% of the variance of the
delayed memory score could be accounted for by years of education; and overall
cognitive function, F (1, 23) = 11.742, p = .002, indicating approximately 34% of the
variance of the overall cognitive score could be accounted for by years of education.

Table 8
Linear Regression of Visuospatial Ability
B

SE

t

p

Entered into Equation
Education

3.784

1.212

3.123

.005

95% C.I.
Lower

Upper

1.278

6.290

Partial Correlation

Excluded from Equation
Income

.016

-

.086

.932

.018

Age at first drink

.156

-

.828

.416

.174

Drinks per day

-.029

-

-.151

.882

-.032
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Table 9
Linear Regression of Immediate Memory Ability
B

SE

t

p

Entered into Equation
Education

2.655

1.247

2.130

.044

95% C.I.
Lower

Upper

.076

5.234

Partial Correlation

Excluded from Equation
Income

.089

-

.449

.657

.095

Age at first drink

-.170

-

-.824

.419

-.173

Drinks per day

.169

-

.824

.419

.173

t

p

95% C.I.

Table 10
Linear Regression of Delayed Memory
B

SE

Entered into Equation
Education

3.283

1.333

2.463

.022

Excluded from Equation

Lower

Upper

.526

6.040

Partial Correlation

Income

-.093

-

-.484

.633

-.103

Age at first drink

.031

-

.152

.881

.032

Drinks per day

-.144

-

-.718

.480

-.151

Table 11
Linear Regression of Overall Cognitive Function
B

SE

t

p

Entered into Equation
Education

3.388

.989

3.427

.002

95% C.I.
Lower

Upper

1.343

5.434

Partial Correlation

Excluded from Equation
Income

-.093

-

-.528

.603

-.112

Age at first drink

-.004

-

-.024

.981

-.005

Drinks per day

-.114

-

-.619

.543

-.131
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Predictors of Treatment Completion
The third hypothesis of the study was that poor index scores on each domain of
the cognitive assessment (RBANS) would have a negative effect on treatment
completion. A preliminary analysis of bivariate correlations was conducted in order to
assess the relationships between cognitive variables and completion. No variables were
significantly correlated with treatment completion. See Table 12.

Table 12
Bivariate Correlations between Cognitive Domains and Completion
Pearson
Correlation

Significance
(2-tailed)

Attention

.003

.990

Language

.396

.050

Visuospatial

-.058

.782

Immediate Memory

.159

.449

Delayed Memory

.375

.065

Overall Cognition

.238

.252

Cognitive Domain

Six hierarchical logistic regressions were conducted in order to investigate if any
of the domains of cognitive function significantly predicted treatment completion, while
controlling for education. In of these six models, years of education were entered in the
first step, and each domain index score was entered in the second step. There were no
significant effects of any of the domains on completion.
In order to further investigate the effect of cognitive function on treatment
completion, the cognitive domain index variables were transformed into dichotomous
variables reflecting: below average, or average and above. A series of six hierarchical
logistic regressions were then performed, with years of education in the first step, and
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each dichotomous cognitive domain variable in the second step. According to these
analyses, average and above delayed memory was a significant predictor of treatment
completion, 2 (1) = 4.910, p = .027. See Table 13 below for coefficients.

Table 13
Hierarchical Logistic Regression Results Predicting Treatment Completion
B

SE

Wald

p

95% C.I.
Lower

Upper

Years of Education

.033

.246

.017

.895

.637

1.674

Delayed Memory

2.112

1.014

4.343

.037

1.134

60.276

Other Risk Factors and Treatment Completion
The final hypothesis of this study was that a comorbid mental health diagnosis
and dropout from prior rehabilitation treatments would have a negative effect on
treatment completion. A preliminary frequency analysis indicated that 16 of the 25
participants had a co-occurring diagnosed mental health condition. 15 of the 25
participants had previously enrolled in an addiction treatment program, with 6 of them
dropping out of treatment. Logistic regressions were used to evaluate the hypothesis
regarding the effect of these variables on treatment completion. The first logistic
regression evaluated whether a co-occurring mental health condition impacted treatment
completion. The second logistic regression analyzed a subset of the original data,
including only those who had previously enrolled in a treatment program. In this
subdataset, a logistic regression evaluated whether prior dropout from treatment impacted
current treatment completion. Neither variable significantly predicted treatment
completion. See Tables 14 and 15.
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Table 14
Logistic Regression of Comorbid Mental Health on Treatment Completion
B
Mental Health

-1.001

SE
.947

Wald
1.118

p
.290

95% C.I.
Lower

Upper

.057

2.351

Table 15
Logistic Regression of Prior Dropout on Treatment Completion
B
Prior Dropout

-.693

SE
1.080

Wald
.412
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p
.521

95% C.I.
Lower

Upper

.060

4.153

CHAPTER FIVE
DISCUSSION

This study examined cognitive deficits in the outpatient Chemical Dependency
Partial Hospitalization Program at the Loma Linda University Behavioral Medical
Center. There were a total of 25 patients who had a primary alcohol diagnosis recruited
for this study during the months of May 2013 to March 2014.
The purpose of this investigation was to identify the cognitive deficits present in
this sample in order to understand the challenges that might be present in this type of
population. Previous studies have suggested that chronic alcohol abuse has been linked to
several cognitive deficits that affect aspects of everyday life, including learning, memory,
abstracting, problem-solving, information processing (Parsons et al., 1998), spatial
processing (Fein et al., 2006), decreased executive functioning (Glass et al., 2009), and
impaired verbal fluency and decision making (Fernandez-Serrano et al., 2010). Other
behavioral disturbances that occur with alcohol use include increased impulsivity and
aggression (Bjork et al., 2004) and proneness to social deviance and disadvantageous
decision-making (Fein et al., 2004). Further older age, lower education, health problems,
psychiatric diagnoses, familial alcoholism, and duration of heavy drinking, have been
inversely related to neuropsychological ability (Bates et al., 2006).
In this study, participants were given a brief neuropsychological battery, the
repeatable battery for the assessment of neuropsychological status (RBANS). This
measure uses twelve subtests to assess cognitive domains of attention, language,
visuospatial ability, immediate memory, delayed memory, and yields an overall cognitive
function score. An analysis of this sample’s subtest scores in comparison to a normative
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sample indicated lower mean scores on the list learning and figure copy subtests,
indicating lower performances on immediate verbal memory and visuospatial ability.
Further, when this sample’s mean index scores were compared to an average index score
of 100, analyses indicated lowered scores on visuospatial abilities, immediate memory,
and overall cognitive function. These results are in agreement with previous research
(mentioned above).
The next hypothesis of this study was that lower income, education, age at first
drink, and higher severity of drinking (measured by number of drinks per day) would be
inversely related with cognitive function. While this study did not entirely confirm these
hypotheses, it did indicate that a higher number of years of education influenced higher
rates cognitive functioning, which is not surprising. One reason the other hypotheses
were not supported could in great part be due to the skewness of high income in this
sample, with half of the participants making over $80,000, which is well over the average
income of $61,000 in the US, according to the US Census Bureau. Further, given the
small sample size, the range in age at first drink and number of drinks per day may not
have been sufficient in detecting a relationship with cognitive function.
Another goal of this study was to examine variables that may be negatively
related to treatment completion. In the addiction treatment program at the Loma Linda
Behavioral Medical Center, of the 25 patients recruited, 16 (64%) patients completed
treatment. This is consistent with previous studies, which report completion rates of
65.2% (Fishman et al., 1999), and attrition rates of 10-30% (Rabinowitz and Marjefsky,
1998). This study hypothesized that lower cognitive function would predict lower levels
of treatment completion, as previous research has suggested (Aharonovich et al., 2006;
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Teichner et al., 2002). While the index scores of the domains of cognitive function did
not significantly predict treatment completion, the analysis comparing completion rates
of those with below average scores to those with average or above delayed memory
scores yielded a result indicating that below average delayed memory scores negatively
impacted treatment completion. The most direct explanation for this finding is that those
with poor delayed memory may find it more difficult to carry over information learned
during their treatment program, directly influencing their motivation to remain in
treatment. With such strong biological and social drives to return to alcohol use, if one
cannot remember the reasons to abstain, treatment compliance may become too difficult.
It is highly likely that the other domains were not predictive of treatment completion due
to insufficient sample size.
The last hypothesis of this study was that other risk variables, such as comorbid
mental health diagnoses and/or previous dropout from treatment would impact treatment
completion rates. Again, this study did not uphold this hypothesis. This could be due to
insufficient sample size, or may suggest that there are other more relevant factors that
influence treatment completion. Investigating symptomatology related to mental health
diagnoses may prove to be more relative to treatment completion than the diagnosis itself.

Limitations
The present study has a number of limitations. First off, the sample size recruited
for this study was very small (n = 25). With a sample of this size, options for data
analyses are not only limited, but are poorly utilizable in establishing significant
relationships between variables. The data regarding alcohol use history should have been
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more specific. For example, the interview should have ascertained how many years each
participant struggled with alcohol abuse versus years of subclinical alcohol use. Further,
the neuropsychological test use, chosen for its short administration time, which was
determined by the treatment program, is not as sensitive as one would need for an
investigation of this nature. A more comprehensive battery, including individual tests for
each domain of cognitive function would be much more appropriate. The ideal battery,
while still accounting for participant effort and time considerations, would include the
Wechsler Adult Intelligence Scale IV - Digit Span subtest, Trail Making Test A & B,
Controlled Oral Word Association tests of Semantic and Phonemic Fluency, California
Verbal Learning Test II, Rey Figure Copy Test, Wechsler Memory Scale IV – Logical
Memory and Visual Reproduction Subtests, and Wisconsin Card Sorting Test. Beck
Depression Inventory and Beck Anxiety Inventory would also be relevant.

Clinical Implications
With these limitations established, it is important to note that this study is still
innovative and fully applicable to the clinical setting at hand. This is the first study
conducted at the Loma Linda BMC that has evaluated cognitive function in their
treatment population. Further, given that half of this sample scored below average on
overall cognitive function, it suggests an area in which program development could
identify as an area of focus. Utilizing this data, the staff and counselors can immediately
start to apply this knowledge to the treatment program. Baseline cognitive assessments
can be helpful in identifying those with cognitive deficits, who may be at higher risk of
dropping out of treatment. If the treatment staff can target and engage these patients, they
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may be able to keep them in treatment longer. With studies showing that longer time in
treatment directly impacts future abstinence (Moos et al., 1995), this can be a very
important clinical factor.

Research Implications and Future Directions
In regards to research implications, this study shows that there may be factors that
affect treatment completion that have not yet been investigated. It will be important to
identify what these factors are in order to improve treatment, and its direct influence on
future abstinence. This study may also generate a need to evaluate site-specific treatment
programs, in order to identify risks for treatment dropout. Further, it may suggest that
individually tailored treatment plans are even more important to treatment, as patients
with different cognitive deficits and associated symptoms may benefit from different
types of interventions.
In regard to future directions, this study has incorporated a repeated measures
protocol, in which participants are being given a cognitive assessment at baseline, and
also at the end of their treatment. This will allow our researchers to investigate whether
participant’s cognitive function changes over time, and in what way. By identifying
deficits that improve, remain constant, or decrease over time, we can theoretically
implement cognitive remediation strategies into the treatment protocol that can directly
address cognitive deficits, and aspire to improve treatment completion rates.

Conclusion
In summary, this study aimed to identify cognitive deficits in the addiction

43

treatment population at the Loma Linda Behavioral Medical Center. According to
previous research and literature, cognitive deficits related to learning, memory,
abstracting, problem-solving, information processing (Parsons et al., 1998), spatial
processing (Fein et al., 2006), decreased executive functioning (Glass et al., 2009), and
impaired verbal fluency and decision making (Fernandez-Serrano et al., 2010) were all
found to be associated with alcohol use and abuse. Although not all of these findings
were not replicated in this population, there were trends in this sample’s data that
suggested reductions in visuospatial abilities, immediate memory, delayed memory, and
overall cognitive function. Further, it was found that below average scores on delayed
memory significantly predicted treatment dropout. This discovery can be utilized in this,
and all, treatment populations, as cognitive deficits can directly impact a patient’s
engagement in and completion of treatment. By identifying those with memory
difficulties as having a lower rate of treatment completion, staff and counselors can target
these patients in order to deepen their engagement in treatment. By retaining these
patients in treatment longer, not only could the LLUBMC’s chemical dependency
treatment program have higher rates of completion, these patients may show benefits of
longer rates of abstinence after finishing treatment. Further, other risk factors such as
lower income, younger age at first drink, and drinking severity as they related to
cognitive function were investigated; however, the results did not support they study
hypotheses. This may have been in part due to small sample size, undetectable range in
prevalence, or simply that these variables are not significantly predictive of cognitive
function. Comorbid mental health diagnoses and prior treatment dropout were also
examined as they related to treatment completion. Again, while the findings of this study
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did uphold the study hypotheses, this may be due to small sample size or poor range in
variable data. This suggests a need for continued research in this area and further
investigation into factors that effect treatment completion. By identifying these factors,
treatment programs may be able to target patients who are at risk for not completing
treatment. By targeting at risk patients, treatment programs may be able to increase
treatment retention rates, improve treatment completion, and in turn, reduce national rates
of addiction relapse in the future.
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APPENDIX A
PARTICIPANT INFORMATION SURVEY

NAME (first and last name):

Today’s Date__________________________________
Demographic Questions
1. Date of Birth: (mm/dd/yyyy) ______/______/__________
2. Gender:

Male/Female (circle one)

3. What city do you live in?
City: ______________________________________
4. Approximately how long have you lived at this address? (Years/Months)
_____________________
5. Race/Ethnicity: (please check one)
_____ Caucasian
_____ Hispanic
_____ African-American/Black
_____ Asian
_____ Other (specify) ____________________________
6. What is your marital status:
[ ]1 Married
[ ]2 Remarried
[ ]3 Widowed
[ ]4 Separated
[ ]5 Divorced
[ ]6 Single, never married
7. What is your highest level of education?
[ ]1 Grade School or Less Education
[ ]2 High school diploma or equivalent (trade school certificate)
[ ]3 Some college or Vocational, Business or Trade School
[ ]4 Associate or Bachelors college degree
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[ ]5

Masters or Doctoral degree

8. Do you have a profession, trade, or skill? ____________________________
9. What is your employment status?
a. Employed full time
b. Employed part time
c. Student
d. Unemployed
10. What type of health insurance do you currently have?
[ ]1 I don’t have any health insurance
[ ]2 Private Insurance, Blue Cross, HMO
[ ]3 Medicare/Medicaid/Medical
[ ]4 Champus/ Champus VA/other military
[ ]5 Other type of insurance:
11. What is your average household income?
a. <10,000
b. 10,000-<35,000
c. 35,000-<60,000
d. 60,000-<80,000
e. 80,000+

Drug and Alcohol history questions
12. Have you previously been in treatment prior for alcohol addiction or drug rehab?
No, skip to question 16
Yes
13. How many times previously have you been in treatment for alcohol addiction or
drug rehab?___________________
14. Did you terminate any of the previous treatments early?
No, skip to question 16
Yes
15. Why did you choose to terminate the previous treatments early?
__________________________________________________________________
16. At what age did you begin drinking alcohol? ___________________
17. On average, how many drinks do you have per day? ___________________
18. On average, how many drinks do you consume in one sitting? _____________
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19. Are there any other drugs you take either regularly or even on occasion?
a.
b.
c.
d.
e.
f.
g.
h.

Heroin: (#times)__________________ (#years)_______________________
Methadone: (#times)_______________ (#years)_______________________
Benzodiazepines (Xanax, Valium, etc.): (#times)_______ (#years)_________
Cocaine: (#times)__________________ (#years)_______________________
Amphetamines (meth, speed, etc.): (#times)_________ (#years)___________
Cannabis: (#times)________________ (#years)_______________________
Hallucinogens (LSD, PCP, mushrooms, etc.): (#times)_____ (#years)______
Inhalants: (#times)__________________(#years)_______________________

20. When was the last time that you had any alcohol or took drugs, other than the
medications given to you in treatment?_______________________
21. How important is it for you to complete treatment for your alcohol/drug
problems? (0-5; 0:not at all, 5:extremely important) ____________

General Health Questions
22. Have you ever had an injury to your brain? (like concussion, trauma..etc.)
No
Yes, please specify________________________________________
23. Are you being treated for any medical illness at this time?
No
Yes, please specify_________________________________________
24. Have you ever been diagnosed with a chronic medical illness? (like cancer,
diabetes, etc.)
No
Yes, please specify_________________________________________
25. Have you ever been diagnosed with a mental health condition (like depression,
bipolar…etc.)
No
Yes, please specify_________________________________________
26. Have you ever been diagnosed with a learning disability? (like ADHD, reading
disability, writing disability, etc.)
No
Yes, please specify_________________________________________

52

27. Are you currently taking any medication?
No
Yes, please specify_________________________________________

Stress
28. What do you feel is your current stress level on a scale of 0-10 with 10 the worst
and 0 no stress at all?

Legal History
29. Was this admission prompted by the criminal justice system?
No
Yes, please specify_________________________________________
30. Are you on probation or parole?
No
Yes

Family History
31. Do you have any relatives that have/had a significant drinking or drug use
problem?
a. Mother
b. Grandmother
c. Grandfather
d. Uncle
e. Aunt
f.
g.
h.
i.
j.

Father
Grandmother
Grandfather
Uncle
Aunt

k. Siblings
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